Use of induced pluripotent stem cells to define genetic factors involved in abnormal myeloproliferation and leukaemia in Down syndrome patients (2011–2014)
- Grant type:
- Fondation Jerome Lejeune
- Researchers:
-
-
Senior Group Leader
Australian Institute for Bioengineering and Nanotechnology
-
- Funded by:
- Fondation Jerome Lejeune
